BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference

  August 12, 2025

   · 

  5 min read
• Press Releases

  Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

  August 12, 2025

   · 

  20 min read
• Press Releases

  Stoke Therapeutics and Biogen Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome

  August 12, 2025

   · 

  14 min read
• Press Releases

  Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

  August 12, 2025

   · 

  1 min read
• Press Releases

  Newron Notes the Publication of New Preclinical Research Suggesting Evenamide Ameliorates Schizophrenia-Related Dysfunction

  August 12, 2025

   · 

  10 min read
• Press Releases

  KalVista Pharmaceuticals Announces Maintenance of Orphan Designation for Sebetralstat in European Union

  August 12, 2025

   · 

  5 min read
• Press Releases

  Altimmune Board of Directors Appoints Jerry Durso as Chairman

  August 12, 2025

   · 

  5 min read
• Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

  August 12, 2025

   · 

  8 min read
• Press Releases

  Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results

  August 12, 2025

   · 

  14 min read
• Press Releases

  vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin

  August 12, 2025

   · 

  2 min read